Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults-A randomized blinded controlled trial.

Publication

Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults-A randomized blinded controlled trial.

Journal Paper/Review - Apr 17, 2023

Sumer Johannes, Keckeis Karin, Scanferla Giulia, Frischknecht Manuel, Notter Julia, Steffen Ana, Kohler Philipp, Schmid Patrick, Roth Bianca, Wissel Kerstin, Vernazza Pietro L, Klein Peter, Schoop Roland, Albrich Werner

Citation

Sumer J, Keckeis K, Scanferla G, Frischknecht M, Notter J, Steffen A, Kohler P, Schmid P, Roth B, Wissel K, Vernazza P, Klein P, Schoop R, Albrich W. Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults-A randomized blinded controlled trial. Front Med (Lausanne) 2023; 10:948787.

Type

Journal Paper/Review (English)

Journal

Front Med (Lausanne) 2023; 10

Publication Date

Apr 17, 2023

Issn Print

2296-858X

Pages

948787

Brief description/objective

has clinical antiviral activity against respiratory viruses and modulates immune functions. In this study, we compared higher doses of new formulations with conventional formulations at lower, preventive doses for therapy of respiratory tract infections (RTIs).